ArticleScience (New York, N.Y.)2017

SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancer.

Ping Mu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.